ReviewBMC health services research2010
A cost minimisation analysis in teledermatology: model-based approach.
Review in BMC health services research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mobile technologies to support healthcare provider to healthcare provider communication and management of care.The Cochrane database of systematic reviews · 2020Pooled it
- Trial
- Mobile teledermatology for a prompter and more efficient dermatological care in rural Mongolia.The British journal of dermatology · 2015Trial
- A Cost-Minimization Analysis of Teleconsultation Versus In-Person Care for Chronic Diseases and Rehabilitation in Medically Underserved Areas of South Korea.Healthcare (Basel, Switzerland) · 2025Article
- Pandemic Pressure: Teledermatology and Health Care Disparities.Journal of patient experience · 2021Article
- Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting.JAMA dermatology · 2021Article
- Determining if Telehealth Can Reduce Health System Costs: Scoping Review.Journal of medical Internet research · 2020Article
- Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption?Journal of the American Academy of Dermatology · 2020Article
- A cost savings analysis of asynchronous teledermatology compared to face-to-face dermatology in Catalonia.BMC health services research · 2018Article
- Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia.JAMA dermatology · 2018Article
- Telemedicine: A systematic review of economic evaluations.Medical journal of the Islamic Republic of Iran · 2017Review
- Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population: A systematic review of the literature.International journal of women's dermatology · 2016Article
- Article
- Development of mHealth system for supporting self-management and remote consultation of skincare.BMC medical informatics and decision making · 2015Article
- The Empirical Foundations of Teledermatology: A Review of the Research Evidence.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2015Review
- [Evaluation of the impact of teledermatology in decreasing the waiting list in the Bages region (2009-2012)].Atencion primaria · 2015Article
- Store-and-forward teledermatology: a case report.BMC research notes · 2014Article
- The empirical foundations of telemedicine interventions for chronic disease management.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2014Review
- Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study.Global & regional health technology assessmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough store-and-forward teledermatology is increasingly becoming popular, evidence on its effects on efficiency and costs is lacking. The aim of this study, performed in addition to a clustered randomised trial, was to investigate to what extent and under which conditions store-and-forward teledermatology can reduce costs from a societal perspective.
methodsA cost minimisation study design (a model based approach) was applied to compare teledermatology and conventional process costs per dermatology patient care episode. Regarding the societal perspective, total mean costs of investment, general practitioner, dermatologists, out-of-pocket expenses and employer costs were calculated. Uncertainty analysis was performed using Monte Carlo simulation with 31 distributions in the used cost model. Scenario analysis was performed using one-way and two-way sensitivity analyses with the following variables: the patient travel distance to physician and dermatologist, the duration of teleconsultation activities, and the proportion of preventable consultations.
resultsTotal mean costs of teledermatology process were €387 (95%CI, 281 to 502.5), while the total mean costs of conventional process costs were €354.0 (95%CI, 228.0 to 484.0). The total mean difference between the processes was €32.5 (95%CI, -29.0 to 74.7). Savings by teledermatology can be achieved if the distance to a dermatologist is larger (> = 75 km) or when more consultations (> = 37%) can be prevented due to teledermatology.
conclusionsTeledermatology, when applied to all dermatology referrals, has a probability of 0.11 of being cost saving to society.In order to achieve cost savings by teledermatology, teledermatology should be applied in only those cases with a reasonable probability that a live consultation can be prevented.
trial registrationThis study is performed partially based on PERFECT D Trial (Current Controlled Trials No. ISRCTN57478950).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.